Apnea Patients Should Keep an Eye Out for Glaucoma

Article

Successfully measuring the eye pressure of people with obstructive sleep apnea (OSA) indicated to scientists for the first time a relationship between sleep apnea and glaucoma.

Successfully measuring the eye pressure of people with obstructive sleep apnea (OSA) indicated to scientists for the first time a relationship between sleep apnea and glaucoma.

Specifically, research from Hokkaido University showed that OSA patients were nearly 10 times more likely than non-OSA patients to suffer from glaucoma — optic nerve disease triggered from increased eye pressure.

To effectively measure eye pressure in sleeping subjects, the research team used a special sensor similar to a contact lens to assess the pressure changes when OSA patients’ breathing stopped during sleep.

Typically, intrathoracic pressure rises if people stop breathing/exhaling, leading to higher eye pressure.

However, during their research, the team unexpectedly found that the eye pressure dropped when study participants stopped breathing. These patients also were likely to stop inhaling, not exhaling, as a result of closed airways, triggering lower intrathoracic pressure.

Additionally, the team noted the patients exhibited hypoxic effects, potentially causing optic nerve damage leading to glaucoma.

The authors concluded that the optic nerve could be damaged as a result of hypoxia without an increase in eye pressure — information that can help dissect the symptoms experienced by glaucoma patients with normal eye pressure levels.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.